Search | Webyourself Social Media Platform

Ben Wood added blog Other
2023-09-28 11:56:37 -

Global Humira Biosimilar Market Is Estimated To Witness High Growth Owing To Growing Prevalence of Autoimmune Diseases & Increasing Patent Expiry of Humira
The Humira Biosimilar Market is estimated to be valued at US$ 772.1 million in 2023 and is expected to exhibit a CAGR of 25.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: The Humira Biosimilar market refers to the market for generic versions of Humira, a widely used medication for treating autoimmune diseases such as...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
Naufan Cmi added blog Other
2024-02-26 12:03:19 -

Humira Biosimilar Market is Anticipated to Witness High Growth Owing to Patent Expiry of Reference Drug
The humira biosimilar market consists of biosimilar versions of the reference biologic drug Humira (adalimumab). Humira is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and others. The introduction of biosimilar versions of Humira provides a more cost effective treatment...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
Sachin Sadgir added blog Other
2023-10-27 11:11:16 -

Humira Biosimilar Market Is Estimated To Witness High Growth
The Humira Biosimilar Market is estimated to be valued at US$ 772.1 Million In 2023 and is expected to exhibit a CAGR of 25.9% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Humira is a monoclonal antibody used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriatic...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
Pooja Salve added blog Health
2024-03-12 10:28:32 -

Let’s Understand the rise of Humira Biosimilar
What are biosimilars?A biosimilar is a biologic medical product that is highly similar to an existing approved branded biologic product, known as the reference product or originator biologic. Biosimilars and their reference products have no clinically meaningful differences in terms of safety, purity, or potency. Biosimilars offer more treatment options and have the potential to reduce...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!